Home hemodialysis

National Kidney Foundation Statement on the ESRD Treatment Choices Model (ETC) and Policies to Improve Kidney Patient Choice

Friday, September 18, 2020 - 6:44pm

NEW YORK, Sept. 18, 2020 /PRNewswire/ -- "The National Kidney Foundation (NKF) is pleased to support the three linchpin policies of the Advancing American Kidney Health (AAKH) initiative finalized this morning.

Key Points: 
  • NEW YORK, Sept. 18, 2020 /PRNewswire/ -- "The National Kidney Foundation (NKF) is pleased to support the three linchpin policies of the Advancing American Kidney Health (AAKH) initiative finalized this morning.
  • "The End Stage Renal Disease (ESRD) Treatment Choices Model finalized by the Center for Medicare and Medicaid Innovation (CMMI) today will dramatically increase the ability of patients to access kidney transplant and home dialysis , which are essential steps toward improving patient centric kidney care.
  • "Kidney transplant is the gold standard treatment for kidney failure for most patients, providing better health outcomes, an improved quality of life, and cost savings when compared to dialysis.
  • The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org .

Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day

Thursday, September 17, 2020 - 1:05am
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200916005511/en/
    Fresenius Medical Care today announced the launch of the organizations first World Patient Safety Day initiative to raise awareness of the importance of ultrapure dialysis fluid for developing economies across Asia Pacific.
  • We have chosen World Patient Safety Day to highlight the importance of this issue.
  • These will begin with an online symposium presented on World Patient Safety Day, Does Ultrapure Dialysis Fluid Matter in Hemodialysis?
  • For more information about Ultrapure Dialysis Fluid, please visit: https://bit.ly/3moMk0Q
    The online symposium Does Ultrapure Dialysis Fluid Matter in Hemodialysis?

Quanta to Host Expert Perspectives Webinar on Home Dialysis

Tuesday, September 15, 2020 - 12:00pm

Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.

Key Points: 
  • Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.
  • The presentation will be followed by a live moderated Q&A with the panel and audience by Tina Tan, Executive Editor at FirstWord MedTech.
  • The management team at Quanta Dialysis Technologies will also be available to discuss SC+, its small, simple and versatile haemodialysis system.
  • How quickly will dialysis be adopted routinely in North America?

Quanta to Host Expert Perspectives Webinar on Home Dialysis

Tuesday, September 15, 2020 - 8:00am

Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.

Key Points: 
  • Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.
  • The presentation will be followed by a live moderated Q&A with the panel and audience by Tina Tan, Executive Editor at FirstWord MedTech.
  • The management team at Quanta Dialysis Technologies will also be available to discuss SC+, its small, simple and versatile haemodialysis system.
  • How quickly will dialysis be adopted routinely in North America?

Analysis on Impact of COVID-19 - Global Dialyzer Market 2020-2024 | Evolving Opportunities with Asahi Kasei Corp. and B. Braun Melsungen AG | Technavio

Tuesday, September 8, 2020 - 7:00pm

The global dialyzer market size is expected to grow by USD 3.19 billion as per Technavio.

Key Points: 
  • The global dialyzer market size is expected to grow by USD 3.19 billion as per Technavio.
  • In addition, the growing preference toward home dialysis is anticipated to boost the growth of the Dialyzer Market.
  • The growing incidence of CKDs such as ESRD and renal diseases is expected to drive the dialyzer market growth.
  • B. Braun Melsungen AG operates its business through various segments such as B. Braun Hospital Care, B. Braun Aesculap, B. Braun Out Patient Market, and B. Braun Avitum.

Omaran Abdeen, MD, FASN, FACP, is recognized by Continental Who's Who

Monday, August 17, 2020 - 7:45pm

Their wide range of patient care services includes a comprehensive Chronic Kidney Disease evaluation, outpatient hemodialysis, and home dialysis.

Key Points: 
  • Their wide range of patient care services includes a comprehensive Chronic Kidney Disease evaluation, outpatient hemodialysis, and home dialysis.
  • Board-Certified Nephrologist, Dr. Abdeen has garnered 26 years of expert knowledge and professional experience in his specialty.
  • Highly in demand, Dr. Abdeen is also affiliated with Providence Holy Cross Medical Center where he is the former Chief of Staff.
  • Dr. Abdeen dedicates this recognition to his mentors and professors, Robert Steiner, MD, and Ravi Mehta, MD.

Hemodialysis and Peritoneal Dialysis Market to Garner $22.16 Bn, Globally, by 2027 at 6.0% CAGR, Says Allied Market Research

Tuesday, August 11, 2020 - 2:00pm

PORTLAND, Ore., Aug. 11, 2020 /PRNewswire/ -- Allied Market Research recently published a report, " Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 20202027".

Key Points: 
  • PORTLAND, Ore., Aug. 11, 2020 /PRNewswire/ -- Allied Market Research recently published a report, " Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 20202027".
  • However, the peritoneal dialysis segment is expected to manifest the highest CAGR of 7.2% from 2020 to 2027.
  • However, the clinics and dialysis centers segment dominated the global hemodialysis and peritoneal dialysis market in 2019, contributing to more than half of the market, as most patients prefer to receive dialysis treatments through services provided by dialysis centers.
  • By region, the global hemodialysis and peritoneal dialysis market across Asia-Pacific, followed by North America, held the largest share in 2019, contributing to more than two-fifths of the market.

Hemodialysis and Peritoneal Dialysis Market to Garner $22.16 Bn, Globally, by 2027 at 6.0% CAGR, Says Allied Market Research

Tuesday, August 11, 2020 - 2:00pm

However, complications in dialysis treatment and reimbursement policy concerns in emerging nations hamper the market.

Key Points: 
  • However, complications in dialysis treatment and reimbursement policy concerns in emerging nations hamper the market.
  • However, the peritoneal dialysis segment is expected to manifest the highest CAGR of 7.2% from 2020 to 2027.
  • However, the clinics and dialysis centers segment dominated the global hemodialysis and peritoneal dialysis market in 2019, contributing to more than half of the market, as most patients prefer to receive dialysis treatments through services provided by dialysis centers.
  • By region, the global hemodialysis and peritoneal dialysis market across Asia-Pacific, followed by North America, held the largest share in 2019, contributing to more than two-fifths of the market.

Baxter Introduces Virtual Peritoneal Dialysis Excellence Academy for Nurses in the U.S.

Wednesday, August 5, 2020 - 1:30pm

As home dialysis rates continue to rise, so does the demand for nurses who have the expertise to successfully manage a PD program.

Key Points: 
  • As home dialysis rates continue to rise, so does the demand for nurses who have the expertise to successfully manage a PD program.
  • With more patients adopting PD therapy every day, Baxter is strongly supporting therapy education for nurses to enable better PD patient experiences and outcomes.
  • The PD Excellence Academy is an easy and convenient way for PD nurses to learn about the field, including up-to-date methodologies and tips, on their time.
  • We are excited to combine forces with Baxter, an industry leader in PD, to merge the science and art of dialysis through the PD Excellence Academy.

Quanta to Present at the LifeSci Partners Summer Symposium

Friday, July 31, 2020 - 1:00pm

Based in the Midlands of the UK, Quanta is a technology-enabled provider of innovative dialysis products and services.

Key Points: 
  • Based in the Midlands of the UK, Quanta is a technology-enabled provider of innovative dialysis products and services.
  • The unobtrusive, simple-to-use and digitally connected design of SC+ is intended to empower more patients to take control of their lives with selfcare and home dialysis.
  • Meanwhile, as a compact, portable and versatile device, SC+ provides flexibility to deliver dialysis across a wide range of use environments and prescriptions.
  • SC+ is not yet FDA cleared and not yet available for sale or use in the USA.